Transient leukopenia associated with topical silver sulfadiazine in burn therapy.
D002056:Burns / Q000188:drug therapy*; D006801:Humans; D007970:Leukopenia / Q000139:chemically induced*; D012837:Silver Sulfadiazine / Q000009:adverse effects* / Q000627:therapeutic use; D013411:Sulfadiazine / Q000009:adverse effects*
D013411:Sulfadiazine; D012837:Silver Sulfadiazine